Q4 FY2025 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: SINOMAB BIO-B(03681) the Revenue is -5.439 M (-152.2%);the EBIT is -45.21 M (-9.98%);the EPS is -0.0226 (+51.68%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
-0.01B152.16%
----
----
EBIT
-0.05B9.98%
----
----
EPS
-0.022651.68%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf